Refine your search

Content type
Tags
Author
Language

161 results found

Analysis PRO
Ask Lexy

Lexology PRO | Brazil, European Union, France, etc. | 2 Jun 2023

ESG: key updates and developments (19 May – 1 June)

A US Supreme Court ruling ends a 16-year battle over wetlands, the European Parliament agrees on corporate sustainability due diligence rules, and Germany introduces a plastic packaging tax – plus other key updates.
Analysis PRO In-house
Ask Lexy

Lexology PRO | China | 31 May 2023

China issues first joint cartel and abuse fine to epinephrine maker

China’s competition authority has for the first time ever sanctioned a company for cartel conduct and abuse of dominance in a single case – slapping an active pharmaceutical ingredient supplier with a €37.7 million penalty.
Commentary
Ask Lexy

Smart & Biggar | Canada | 31 May 2023

Federal Court dismisses motion to adjourn section 8 trial to complete document production from non-party generics

Dr. Reddy's (DRL) is seeking damages from Janssen for its lost sales of abiraterone acetate after Janssen's patent was found to be invalid. Janssen has pleaded that if DRL had entered the market earlier than its date of approval in the real world, other generic pharmaceutical companies, including Apotex, would have competed with DRL. Apotex appealed an order to produce documents relevant to......
Article
Ask Lexy

Buchalter | USA | 31 May 2023

Toxic-Free Cosmetic Act Enacted in Washington State

Governor Jay Inslee signed HB 1047, Washington State's Toxic-Free Cosmetic Act (the Act) into law on May 15, 2023. The Act bans some of the most…
Article
Ask Lexy

Kurtin PLLC | Global, USA | 22 May 2023

Biotech, Pharma & Chemicals Master Distribution Agreement Sample Term Sheet: Deal Points

The Biotechnology, Pharmaceutical and Chemicals sectors often outsource the supply and distribution of certain classes…
Article
Ask Lexy

Taylor Wessing | European Union | 10 May 2023

The European Commission's pharmaceutical reform package: core objectives and planned changes at a glance

The European Commission presented its draft for a comprehensive reform of the pharmaceutical legislation on 26 April 2023. The so-called EU Pharma…
Article
Ask Lexy

Accura Advokatpartnerselskab | European Union | 28 Apr 2023

Proposed overhaul of regulation of pharmaceuticals in the EU

On 26 April 2023, the EU Commission published its awaited proposals to reform the regulation of pharmaceuticals in the EU. The reform aims to…
Article
Ask Lexy

Accura Advokatpartnerselskab | Denmark | 28 Apr 2023

Revision of ENLI’s Guidance on the Promotion Code

The Danish Ethical Committee for the Pharmaceutical Industry (ENLI) has issued a revised version of its Guidance on the Promotion Code (the Guidance)…
Commentary
Ask Lexy

Westerberg & Partners Advokatbyrå AB | Sweden | 24 Apr 2023

When can a preliminary injunction be granted ex parte?

This case discussed in this article examines the conditions under which a preliminary injunction can be granted ex parte. While the Patent and Market Court of Appeal ultimately found that those conditions were not met in the case at hand, the ruling poses interesting questions on the traditionally restrictive Swedish view on ex parte preliminary relief in patent cases. The case shows that a......
Commentary
Ask Lexy

Lee and Li Attorneys at Law | Taiwan | 24 Apr 2023

Court rules in favour of pharmaceutical companies that market category two new drugs

When the Patent Linkage Registration System was first launched, accounts were set up specifically for the marketing authorisation holders of category two new drugs to submit their patent information. The Food and Drug Administration (TFDA) subsequently decided to delete such accounts. The Taipei High Administrative Court recently overturned the TFDA's decisions in a judgment that will have a......
Previous page 1 2 3 ...